|1.||Bogdanova, E O: 1 article (01/2003)|
|2.||Gorelov, A I: 1 article (01/2003)|
|3.||Komiakova, B K: 1 article (01/2003)|
|1.||Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
01/01/1983 - "VAB-6 is effective in the prevention of recurrences in resected Stage II-B nonseminomatous germ cell tumors. "
05/01/1988 - "[A case report of extragonadal germ cell tumor with special reference to VAB-6 therapy]."
03/15/1983 - "Forty-four patients with nonseminomatous germ cell tumors with "poor prognostic features" were entered on the VAB-5 regimen and 38 are evaluable. "
11/01/1982 - "Fourteen previously untreated patients with metastatic nonseminomatous germ cell cancer of the testis (NSGC) were treated with a modified VAB-4 regimen which was designed to reduce treatment-related morbidity. "
08/15/1982 - "Fourteen previously untreated patients with metastatic nonseminomatous germ-cell cancer of the testis (NSGC) were treated with a modified VAB-4 regimens that was designed to reduce treatment-related morbidity. "
01/01/2003 - "Seminoma was treated with telegamma radiation from the ROCUS-M installation; cases of non-seminoma pathology received VAB-6 and BEP regimes. "
10/01/1991 - "Thus, VAB-6 and CP regimens seem to have compatible and high activity in disseminated seminoma."
03/01/1985 - "Thirty patients with advanced seminoma were treated with VAB-6. "
03/01/1985 - "VAB-6 as initial treatment of patients with advanced seminoma."
03/01/1985 - "VAB-6 is effective treatment for patients with advanced seminoma, and chemotherapy is recommended as the initial therapy in all patients with stage II seminoma with disease larger than 5 cm, extragonadal seminoma, and stage III seminoma."
|3.||Testicular Neoplasms (Testicular Cancer)
02/01/1988 - "Although 70% of patients with disseminated testicular cancer will achieve a disease-free status with PVB or VAB-6 therapy, there still remains a patient population eligible for salvage therapy. "
01/15/1983 - "VAB-6 combination chemotherapy without maintenance in treatment of disseminated cancer of the testis."
01/01/1983 - "VAB-6 combination chemotherapy in resected stage II-B testis cancer."
07/01/1981 - "VAB-6 combination chemotherapy in disseminated cancer of the testis."
01/01/1991 - "In order to elucidate the mechanism of elevation of alpha-fetoprotein (AFP) which we often observed during VAB-6 chemotherapy, we analyzed sequential changes of AFP, liver enzymes and bilirubin in 10 patients with evaluable disseminated testicular cancer who were treated with VAB-6 chemotherapy. "
03/01/1987 - "The response and survival of the 39 patients with nonseminomatous tumors were found to be identical to the results of 29 patients with nonseminomatous GCTs and poor-risk characteristics who were treated with VAB-6 alone. "
06/01/1991 - "[A randomized trial of PVB, VAB-6, BVP regimen versus PEB chemotherapy in patients with disseminated testicular tumors]."
01/01/1991 - "In each patient, marked tumor regression occurred as a result of VAB-6 chemotherapy. "
10/01/1988 - "After four sessions of VAB-6 combined chemotherapy, the abdominal tumor, 14.1 x 12.3 cm in size, decreased to 5.7 x 4.4 cm ( a regression rate of 85.5%). "
10/01/1988 - "[A case of bilateral testicular tumors showing remarkable regression of huge metastatic tumors after VAB-6 combined chemotherapy]."
|5.||Neoplasm Metastasis (Metastasis)
02/01/1988 - "The other case received VAB-6 therapy with complete response for liver metastasis. "
01/01/1988 - "PVB or VAB-6 combination chemotherapy was given to 41 funicular orchiectomized cases of unresectable retroperitoneal metastases of nonseminoma testicular tumors. "
11/01/1988 - "Efficacy and toxicity of VAB-6 combinations with bleomycin, bleomycetin or peplomycin were studied in treatment of 77 patients with metastases of germ-cell tumors: testicle tumors in 71 patients and extragonadal tumors in 6 patients. "
02/01/1990 - "As pulmonary metastases developed after RPLND, the patient was treated with 3 courses of VAB-6 combination chemotherapy (vinblastine, actinomycin-D, cyclophosphamide, bleomycin and cis-platinum). "
01/01/1990 - "Sixteen patients with metastases of germ cell tumours were given VAB-6 combination chemotherapy including vinblastine, actinomycin-D, cyclophosphamide, bleomycin and platidiam (cis-platin). "
|3.||Etoposide (VP 16)
|5.||Vinblastine (Vinblastine Sulfate)
|1.||Drug Therapy (Chemotherapy)
|3.||Combination Drug Therapy (Combination Chemotherapy)